Aurobindo gains on completing acquisition of select Western European Businesses of Actavis

02 Apr 2014 Evaluate

Aurobindo Pharma is currently trading at Rs. 543.85, up by 9.15 points or 1.71% from its previous closing of Rs. 534.70 on the BSE.

The scrip opened at Rs. 539.05 and has touched a high and low of Rs. 544.25 and Rs. 535.45 respectively. So far 37,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 544.75 on 05-Mar-2014 and a 52 week low of Rs. 138.45 on 06-Aug-2013.

Last one week high and low of the scrip stood at Rs. 544.25 and Rs. 504.50 respectively. The current market cap of the company is Rs. 15,850.00 crore.

The promoters holding in the company stood at 54.73% while Institutions and Non-Institutions held 31.56% and 13.71% respectively.

Aurobindo Pharma has completed the acquisition of certain commercial operations in Western Europe from Actavis plc. The agreement to acquire the Actavis operations was announced in January 2014. The company acquired personnel, commercial infrastructure, products, marketing authorizations and dossier licence rights in seven European countries. Actavis and Aurobindo have also entered into a long term commercial and supply arrangement.

Following receipt of clearances from competent authorities, Aurobindo now intends to combine the strength of both enterprises (including its vertically integrated platform and existing commercial infrastructure) in these markets and to identify and maximize all opportunities to improve performance.

The acquisition will make the company one of the leading Indian pharmaceutical companies in Europe. The acquisition will also enable Aurobindo to achieve critical mass in Western Europe with a top 10 position in several key markets.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up.

Aurobindo Pharma Share Price

1191.20 4.00 (0.34%)
31-Dec-2025 14:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.70
Dr. Reddys Lab 1272.70
Cipla 1510.10
Zydus Lifesciences 914.65
Lupin 2113.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×